HIV and Infection Risk: Understanding Immune System Vulnerability

Why HIV Increases Infection Susceptibility

HIV targets CD4⁺ T helper cells, the orchestrators of adaptive immunity. Their depletion creates a multi-layered immune deficit:

  1. CD4⁺ T-cell loss: Direct infection and bystander apoptosis reduce numbers below the functional threshold (<200 cells/µL = AIDS).
  2. Impaired residual CD4⁺ function: Even surviving cells show defective proliferation, cytokine production, and memory formation.
  3. Chronic immune activation: Persistent viral replication drives inflammation, exhausting immune cells and damaging lymphoid architecture.
  4. Opportunistic infections (OIs): Pathogens controlled by intact immunity reactivate or cause severe disease:
    • Bacterial: TB, Pneumocystis, bacterial pneumonia
    • Fungal: Cryptococcus, Histoplasma, Coccidioides
    • Viral: CMV, HSV, VZV, KSHV (Kaposi sarcoma)
    • Parasitic: Toxoplasma, Cryptosporidium
  5. Latent infection reactivation: Especially TB (lifetime risk 10%/year with HIV vs. 10% lifetime without).
  6. Mucosal barrier breakdown: Gut CD4⁺ depletion → microbial translocation → systemic inflammation.
  7. Humoral immunity impairment: B-cell dysregulation → poor antibody responses to new antigens and vaccines.

ART Transforms Outcomes

Effective antiretroviral therapy (ART) suppresses viremia, restores CD4⁺ counts, reverses immune activation, and prevents most opportunistic infections. With early treatment, life expectancy approaches normal.

HIV & AIDS - Related Articles